Category: Asean

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients with Alzheimer’s disease.

The Phase 2 clinical trial is a multicenter, randomized, double-blind, placebo-controlled phase study to evaluate the safety and efficacy of RP902 in the treatment of mild cognitive impairment (MCI) due to Alzheimer’s Disease. The primary endpoint is the change from baseline in the Clinical Dementia Rating Scale–Sum of Boxes (CDR-SB) score.

The study is co-led by Professor Yi Tang from Xuanwu Hospital affiliated to Capital Medical University, and Professor Yongjun Wang from Beijing Tiantan Hospital affiliated to Capital Medical University.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition and daily functioning. In China, the prevalence of Alzheimer’s disease among people aged 65 and above has reached 6.0%, with approximately 1 in every 17 individuals affected¹, highlighting a significant unmet need for therapies with improved efficacy, safety, and patient adherence.

About RP902
RP902 is an oral small-molecule drug for AD, targeting patients with mild cognitive impairment (MCI) due to Alzheimer’s disease who are apolipoprotein E ε4 (ApoE ε4) carriers, with the potential to become a first-in-class disease-modifying therapy. ApoE ε4 carriers typically experience earlier disease onset and faster progression, with limited treatment options currently available.

Preclinical studies of RP902 have demonstrated it significantly inhibits neurotoxic Aβ oligomers and improves cognitive function. RP902 has completed Phase 1 clinical trials with favorable safety and tolerability and has initiated Phase 2 clinical studies (NCT07579884).

Compared with existing therapies, RP902 has the potential to delay disease progression, with a favorable safety profile and the convenience of oral administration, offering a differentiated treatment option for Alzheimer’s disease patients carrying the ApoE ε4 allele.

About Risen (Shanghai) Pharma Tech Co., Ltd.
Risen Pharma is an internationally competitive clinical-stage biotech company focusing on developing and commercializing highly-needed, patient-accessible therapeutics. The company’s integrated capabilities cover all stages of drug development, including lead identification and optimization, preclinical evaluation, clinical development, and commercialization. Risen specializes in neurodegenerative diseases like Alzheimer’s, leveraging small molecules, PROTACs, and siRNA technologies to develop a comprehensive therapeutic platform encompassing prevention through treatment. Based on strong in-house R&D capabilities, the company has advanced over 20 innovative drug candidates and built a differentiated pipeline in degenerative and metabolic diseases, autoimmune diseases, cancers, and infectious diseases.

Media Contact
Company Name: Risen (Shanghai) Pharma Tech Co., Ltd.
Contact Person: Wenbing Yu
Email: [email protected]
Website: http://www.risen-pharma.com/

References

1. LI, Y. F., & JI, Y. (2026). Consensus on diagnostic criteria for Alzheimer’s disease. Chinese Journal of Contemporary Neurology & Neurosurgery, 26(2).

GlobeNewswire Distribution ID 9722014

Milestone Move to IMS on AWS Achieved as Operator Transitions 
Fixed and Mobile Subscriber Base to Mavenir’s Web-Scale IMS Solution

RICHARDSON, Texas, May 18, 2026 (GLOBE NEWSWIRE) — Mavenir, the software company building Cloud-Native, AI-by-design mobile networks, today announces that Telefónica Germany has successfully migrated the first 100K mobile customers to 4G/5G voice services on Mavenir’s cloud-native IMS solution built on the Amazon Web Services (AWS) Cloud. Telefónica Germany is now the first mobile operator in Europe to deploy such a capability with production subscribers in a public cloud. The migration milestone was achieved in Q1 2026 as part of a multi-year transformation project spanning both fixed and mobile IMS networks.

Under a multi‑year contract extension announced with Telefónica Germany in February 2025, Mavenir began extensive lab validation ahead of moving the operator’s 4G/5G voice services in Germany from Mavenir’s virtualized IMS (vIMS) to Mavenir’s cloud‑native IMS platform. Both companies are developing a comprehensive automation framework, which is expected to streamline operations and accelerate the delivery of new features and updates. During 2026, Mavenir expects to migrate the first few million mobile customers to the new solution running on AWS Cloud. The full migration is scheduled for next year, with all sites set to be deployed using automation.

Matthias Sauder, leading Technology & Unified Connectivity at Telefónica Germany, commented: “This milestone marks a pivotal stage in transitioning our core network and telecom workloads to public cloud infrastructure. Telefónica Germany’s cloud strategy is built on our firm belief in agility, transparency and advanced automation, and this migration of our mobile voice services to Mavenir’s cloud-native IMS solution reflects our progressive vision for evolving beyond traditional network models. Mavenir has been a trusted and proven partner in delivering best quality, future ready services. We are looking forward to driving the next phase of our network evolution jointly – unlocking new levels of efficiency and innovation and creating new value for our customers and across our operations.”

Brandon Larson, SVP & General Manager, Cloud, AI & IMS Business Strategy at Mavenir, added: “We share this achievement with Telefónica Germany as it uplifts the first 100,000 customers to 4G/5G voice services on our IMS solution running seamlessly on AWS. Forward‑thinking operators are embracing cloud technologies to prepare for an AI‑native, fully automated future, and this transition demonstrates Telefónica Germany’s clear leadership in that journey. Mavenir’s cloud‑native IMS provides the foundation to modernize and future‑proof mobile voice services, enabling new levels of agility while unlocking AI‑driven innovation and fresh monetization opportunities for the years ahead. Today’s milestone is an important step in realizing Telefónica Germany’s strategic shift to cloud-native technologies, and a validation of its ongoing trust in Mavenir as a partner for the next era of network cloudification and automation.”

Mavenir’s cloud-native, web-scale IMS solution delivers the foundational technology for next-generation mobile networks, supporting voice over LTE (VoLTE), voice over New Radio (VoNR) and voice over Wi-Fi (VoWi-Fi) and Voice over NTN on a unified IMS core and ensuring seamless voice continuity across 4G, 5G and beyond. Designed to run on any public, private or hybrid cloud, Mavenir IMS services are deployed as stateless, containerized microservices that are purpose-built for fully automated cloud environments – empowering operators to accelerate innovation and introduce new services at scale and at pace.

About Mavenir
Mavenir is enabling intelligent, automated, programmable networks through the development of telco-first, cloud-native, AI-by-design software solutions for mobile operators. The company’s deep telco domain expertise has been proven through deployments with 300+ operators globally in over 120 countries, which together serve more than 50% of the world’s subscribers. Mavenir combines its deep telco experience with the cloud and IT expertise and data science skillsets essential to solving real customer challenges. Its proven software solutions are AI by design, delivering the AI-native future and operators’ evolution to TechCos. ​For more information, please visit www.mavenir.com

Media Contacts

Mavenir PR Contacts:
Emmanuela Spiteri
[email protected]

GlobeNewswire Distribution ID 9721985

Ahead of Russian President Vladimir Putin’s visit to China from May 19 to 20, CGTN has published an article examining the evolution of China-Russia relations at a historically significant moment.

The piece highlights how sustained head-of-state diplomacy has strengthened political mutual trust and how China and Russia have developed a model of major-country relations characterized by mutual respect, peaceful coexistence and win-win cooperation, offering a clear example of stability and continuity in a turbulent world.

BEIJING, May 17, 2026 (GLOBE NEWSWIRE) — At the invitation of Chinese President Xi Jinping, Russian President Vladimir Putin will pay a state visit to China from May 19 to 20, a fresh demonstration of the close high-level exchanges that have become a distinctive feature of China-Russia relations in the new era.

Putin’s visit comes at a historically significant moment. This year marks the 25th anniversary of the signing of the China-Russia Treaty of Good-Neighborliness and Friendly Cooperation and the founding of the Shanghai Cooperation Organization (SCO), as well as the 30th anniversary of the establishment of the China-Russia comprehensive strategic partnership of coordination.

Over the past decade, head-of-state diplomacy has played a central role in steering bilateral ties through a rapidly changing global landscape. Since 2013, Xi and Putin have maintained frequent interactions. Xi has visited Russia 11 times, while Putin has traveled to China 13 times, underscoring the enduring strength and strategic nature of bilateral relation

Head-of-state diplomacy provides strategic guidance

“The frequency and depth of their interactions are rarely seen anywhere else in the world,” said Zhao Long, a research fellow at the Center for Russian and Central Asian Studies at the Shanghai Institutes for International Studies.

He noted that the two leaders have met more than 40 times over the past decade, and that head-of-state diplomacy has become a strong pillar of the high level of mutual trust and a key driving force behind practical cooperation across a wide range of sectors.

In March 2013, Russia became the first country Xi visited after taking office as Chinese president. In 2019, the two sides upgraded bilateral relations to a comprehensive strategic partnership of coordination for a new era, the highest level in the history of bilateral relations.

In 2025, Putin visited China to attend the SCO summit and commemorative events marking the 80th anniversary of the victory in the Chinese People’s War of Resistance against Japanese Aggression and the World Anti-Fascist War. On February 4 this year, Xi and Putin held a video meeting to discuss future development of bilateral ties and their coordination on international platforms.

Under the guidance of the two heads of state, China and Russia have continuously deepened political mutual trust and firmly supported each other on issues concerning their core interests, including sovereignty, security and development. The two sides have also strengthened coordination on major international platforms such as the United Nations, SCO, BRICS, APEC and the G20, jointly opposing unilateralism and contributing to build a multipolar world.

Xi has previously stated that China and Russia have explored a new path for neighboring major countries to get along with each other, characterized by non-alliance, non-confrontation, and not targeting any third party, setting an example of a new type of major-country relations.

Practical cooperation reaches new heights

With deepening political mutual trust, the two countries have achieved fruitful results through extensive practical cooperation across fields such as trade, energy, and culture.

Faced with global headwinds, the two countries’ economic and trade cooperation has continued to expand, with the two sides actively advancing the alignment between the Belt and Road Initiative (BRI) and the Eurasian Economic Union. More than 70% of China-Europe freight trains under the BRI pass through Russia en route to Europe, with the number of trips continuing to reach record highs.

China has remained Russia’s largest trading partner for 16 consecutive years. According to the latest data from China’s Ministry of Commerce, bilateral trade reached $227.9 billion in 2025, surpassing the $200 billion mark for the third consecutive year. In the first quarter of this year, bilateral trade totaled $61.2 billion, up 14.7% year on year.

People-to-people exchanges have also continued to flourish. The two countries have jointly organized a range of exchange programs over the years, including language years, tourism years, youth exchange years and cultural years.

During the 2024-2025 China-Russia Years of Culture, the two countries held a series of cultural exchange activities. The original Chinese dance drama Wing Chun was performed at Moscow’s Bolshoi Theatre, while performances in China by Russia’s Mariinsky Theatre Orchestra and the Bolshoi Ballet were met with overwhelming demand. In 2025, China and Russia also introduced a mutual visa-free policy, triggering a tourism boom between the two countries.

From deepening political mutual trust to expanding practical cooperation and growing people-to-people exchanges, China and Russia have continued to strengthen their bilateral friendship.

Against a backdrop of growing global uncertainty, the upcoming meeting between the two heads of state is expected to further advance bilateral ties, deliver greater benefits to the two peoples, and contribute more stability and positive momentum to a changing world.

https://news.cgtn.com/news/2026-05-17/Head-of-state-diplomacy-anchors-growing-China-Russia-partnership-1NdoTiyrmVi/p.html

Contact:
CGTN Digital
[email protected]

GlobeNewswire Distribution ID 9721804